|
Submit a Poster Abstract
The Poster Abstract deadline is January 8, 2010. Three to five page, double spaced abstracts should be submitted via our Online Submission Form. Send special requests to Richard Dalby.
Respiratory Drug Delivery has a track record of producing high quality abstracts for distribution to conference participants at the meeting. It is essential that you follow these guidelines carefully before beginning your poster abstract and observe the strict deadlines. Failure to do so may result in your abstract being omitted from the proceedings and/or the meeting.
RDD 2010 welcomes poster abstracts on all subjects related to pulmonary and nasal medication delivery. To ensure the maximum chance of poster acceptance your abstract should:
- Be written using simple scientific language to describe recent experiments, innovations and insights.
- Include data, new concepts or approaches.
- Ensure that all claims and conclusions are supported by data or references, especially those making comparisons to competing products.
- Please do not submit work that has been presented at other meetings. However, your are welcome to send us work that builds on previous RDD presentations or those made elsewhere.
General Instructions
- Prepare your poster paper according to the Poster Abstract Guidelines.
- Click here to view an example of a submitted poster abstract.
- Click here to see what the same abstract looks like when it is typeset.
- Submit your poster abstract online by January 8, 2010.
- Only one Microsoft® Word (.doc or .docx) file smaller than 2 MB may be uploaded. Use the "Browse" button to select the file you want to upload.
- If your file is larger than 2 MB or if you absolutely must submit multiple files, or a file in a different format, please complete the online submission process and indicate in the "Comments" box that you will send the abstract via email to Richard Dalby.
Please remove all 'Track Changes' and 'Comments' before you submit your files.
- Once you have submitted your abstract you will receive an email acknowledging receipt. Shortly afterwards, your name and poster title will be visible on the RDD 2010 Abstracts Received page where you can check the status of your abstract at any time.
- Our review team will evaluate your poster paper and let the primary author know by e-mail if it has been accepted for presentation at RDD 2010 between January 25 - February 8, 2010. Reviewers may accept, reject or request modifications to poor quality papers. Please make any corrections or alterations within 7 days.
- Obtain Copyright Permission from the original publisher to use any copyrighted materials that appear in your poster paper.
- Send revised electronic copies of your final poster abstract to Richard Dalby and Jill Cone. February 15, 2010 is the absolute deadline for receipt of revised poster papers. We may ask for a hard copy of your poster paper to help with formatting.
Richard N. Dalby, Ph.D.
Department of Pharmaceutical Sciences
University of Maryland
School of Pharmacy
20 N. Pine Street
Baltimore, MD 21201, USA
Email: rdalby@rx.umaryland.edu
Phone: (410) 706-3245
Fax: (410) 706-0346
Jill Cone
Davis Healthcare International Publishing
415 Jaslie Drive
Cary, NC 27518
Phone: (919) 858-9400
Fax: (877) 213-8573
Email: jtcone@earthlink.net
- Send a signed Copyright Transfer Form to Respiratory Drug Delivery by courier or fax. We cannot publish your poster paper if Copyright is not released by the February 15, 2010 deadline.
Respiratory Drug Delivery
Virginia Biotech Research Park
800 East Leigh Street, Suite 10
Richmond, VA 23219, USA
E-mail: info@rddonline.com
Phone: (804) 827 1490
Phone: (804) 828 8277
- The Publisher will typeset your abstract and email Acrobat (.pdf) proofs for you to correct. You should return the proofs by email within 48 hours of receipt. Please make typographical corrections only – it’s too late to change the text!
- Prepare your poster according to the RDD Poster Session Guidelines.
Please direct any questions or special requests about this event to Richard Dalby. |
